The Latest Breaking News from UNAIDS

Speaking at the 16th International Aids Conference in 2006, the then UNAids executive director, Peter Piot, remarked: “Since the beginning of the epidemic, stigma, discrimination and gender inequality have been identified as major causes of personal suffering, and as major obstacles to effective responses to HIV.”

A twice-yearly shot that prevents HIV infections will be available at low cost in 120 poor countries

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – three times more than the 370,000 target set by UNAids. In sub-Saharan Africa, HIV…

Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations said Tuesday, warning that this decline was still far too slow.

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

It’s a worrying question for health officials in one of the richest and most developed areas of the African continent: Why are babies being born with HIV when free medication is available to prevent mother-to-child transmission

Twenty years since antiretroviral therapy was rolled out in the country, HIV/AIDS patients are living full lives.

A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa

Nearly 40 million people were living with the HIV virus that causes AIDS last year, over 9 million weren’t getting any treatment, and the result was that every minute someone died of AIDS-related causes, the U.N. says in a new report

Explore UNAIDS report on global HIV/AIDS trends, challenges, and efforts to improve treatment accessibility.

Gilead could bring the AIDS pandemic towards an end if the US pharmaceutical giant opens up access to its game-changing new HIV drug, the head of UNAIDS told AFP. Winnie Byanyima urged Gilead to "make history" by allowing generic manufacturing of Lenacapavir, a twice-yearly injectable antiretroviral medication used to treat…